New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

They are affected as a result of impairment in inhibitors such as complement factor H (FH), C1-inhibitor (C1INH), tissue factor pathway inhibitor (TFPI), and alpha-2-macroglobulin (A2M). Moreover, the ...

For many people, the end of the year is a mad rush to wrap things up before the holidays, and so it was for the FDA. Notable regulatory decisions include the first drug approval for a prevalent ...

Per Pfizer, Hympavzi targets tissue factor pathway inhibitor (TFPI), which is a natural anticoagulation protein that functions to prevent the formation of blood clots. Year to date, shares of ...